Cromi and Hofseth Biocare Announce Merger
Cromi will bring its competence and market networks to Hofseth Biocare and its unique ingredients and products know how.
Aug 25 2011 --- Hofseth BioCare, through significant investments in technology, research and testing, has developed a new method for fully controlled marine bi-product refinement. This unique production method is based on hydrolysis technology and use of enzymes.
Hofseth Biocare has designed the ultimate enzymes for the production process in close cooperation with leading enzyme producers. The hydrolysis technology combined with specific enzymes allows better separation of the raw material at low temperatures. It also prevents oxidation and offers high-quality product fractions of protein, calcium and fish oil.
Cromi will bring to HBC a unique market competence and extensive network in the Nutrition Industry. Cromi is a European consultancy group with a high competence in export and strategic consultancy within the healthy ingredients market. During the past years, Cromi has been recognized as the most knowledgeable consultant company within the Omega-3 market and it has been working with the most important producers of Omega-3 in the world. Cromi will bring its competence and market networks to Hofseth Biocare and its unique ingredients and products know how.
